CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : Connecticut
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All

CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : Connecticut

Filetype[PDF-403.79 KB]

  • Description:
    $2,310,113 Funding for AR Activities Fiscal Year 2017 One of 10 sites for the Emerging Infections Program Candida auris, a resistant fungus that can cause deadly infections, was identified in Connecticut. CDC provides Connecticut with resources to identify and contain resistant infections, like C. auris. After C. auris emerged in the U.S. in 2016, the AR Lab Network regional labs also began providing specialized testing to states fighting this new threat. Funding to local health departments: $635,541 - RAPID DETECTION & RESPONSE to emerging drug-resistant germs is critical to contain the spread of these infections. With 2016 funding, Connecticut’s HAI/AR program has worked with clinical partners and the state public health laboratory to develop a “nightmare bacteria” CRE testing panel and efficient reporting process. The data generated helps guide infection prevention and control in Connecticut’s healthcare facilities and leads to faster detection and containment of CRE outbreaks. $390,382 - FOOD SAFETY projects protect communities by rapidly identifying drug-resistant foodborne bacteria to stop and solve outbreaks and improve prevention. Connecticut implemented whole genome sequencing of Listeria, Salmonella, Campylobacter and E. coli isolates submitted to its lab and began uploading sequence data into PulseNet for nationwide monitoring of outbreaks and trends. In Fiscal Year 2018, Connecticut will begin simultaneously monitoring these isolates for resistance genes. When outbreaks are detected, local CDC-supported epidemiologists investigate the cases to stop spread. $1,284,190 - EMERGING INFECTIONS PROGRAM (EIP) sites improve public health by translating population-based surveillance and research activities into informed policy and public health practice. CDC’s EIP network is a national resource for surveillance, prevention and control of emerging infectious diseases—like antibiotic-resistant bacteria and fungi. Learn more: Publication date from document properties. Connecticut-2017-CDC-AR-Investments.pdf
  • Place as Subject:
  • Main Document Checksum:
  • File Type:
  • Supporting Files:
    No Additional Files

You May Also Like: